Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Acta Neuropathol. 2014 Apr 29;127(6):897–909. doi: 10.1007/s00401-014-1272-4

Table 2. Genetic characterization of VU-DIPG-3 and -5 human tumors and murine xenografts.

DNA from m-VU-DIPG-3 and -5 was isolated from subcutaneous tumor at transplant generation 1 and 2, respectively. n.a.: not analyzable.

VU-DIPG-3 VU-DIPG-5
human murine human murine
Specific mutation
H3F3A K27M + +
H3F3A G34R
HIST1H3B K27M
PI3KCA H1047R
PI3KCA H1047L
PI3KCA E542K
Amplification
EGFR n.a. n.a.
PTEN Deletion n.a.
PDGFR-α n.a. n.a.
Array CGH profile
Human 180K Gain 1q, loss 17p (distal) n.a. n.a. n.a.
Mouse 180K n.a. Loss 4 (C4-C5), gain 4 (C5-D2.2) n.a. n.a.